Preview this article:
Zoom in

Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against , Page 1 of 1

| /docserver/preview/fulltext/jmm/63/5/760_jmm072306-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. Baig A. M., Iqbal J., Khan N. A. 2013; In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype. Antimicrob Agents Chemother 57:3561–3567 [CrossRef][PubMed]
    [Google Scholar]
  2. Brunton L. L., Chabner B. A., Knollman B. C. 2011 Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12th edn. New York: McGraw-Hill;
    [Google Scholar]
  3. Marciano-Cabral F., Cabral G. A. 2007; The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol 51:243–259 [CrossRef][PubMed]
    [Google Scholar]
  4. Siddiqui R., Khan N. A. 2011; Rigorous ablution is a potential risk factor to fatal brain infection in developing countries. J Infect 63:487–488 [CrossRef][PubMed]
    [Google Scholar]
  5. Visvesvara G. S., Moura H., Schuster F. L. 2007; Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 50:1–26 [CrossRef][PubMed]
    [Google Scholar]
  6. Yousuf F. A., Siddiqui R., Subhani F., Khan N. A. 2013; Status of free-living amoebae (Acanthamoeba spp., Naegleria fowleri, Balamuthia mandrillaris) in drinking water supplies in Karachi, Pakistan. J Water Health 11:371–375 [CrossRef][PubMed]
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error